Dr. Reddy's Laboratories Limited and Bio-Techne Corporation: A Comprehensive Revenue Analysis

Comparing revenue growth of Dr. Reddy's and Bio-Techne over a decade.

__timestampBio-Techne CorporationDr. Reddy's Laboratories Limited
Wednesday, January 1, 2014357763000132170000000
Thursday, January 1, 2015452246000148189000000
Friday, January 1, 2016499023000154708000000
Sunday, January 1, 2017563003000140809000000
Monday, January 1, 2018642993000142028000000
Tuesday, January 1, 2019714006000153851000000
Wednesday, January 1, 2020738691000174600000000
Friday, January 1, 2021931032000189722000000
Saturday, January 1, 20221105599000214391000000
Sunday, January 1, 20231136702000245879000000
Monday, January 1, 20241159060000279164000000
Loading chart...

Infusing magic into the data realm

A Decade of Growth: Dr. Reddy's Laboratories vs. Bio-Techne

In the ever-evolving landscape of pharmaceuticals and biotechnology, Dr. Reddy's Laboratories Limited and Bio-Techne Corporation have emerged as significant players. Over the past decade, Dr. Reddy's has consistently outpaced Bio-Techne in revenue, showcasing a robust growth trajectory. From 2014 to 2024, Dr. Reddy's revenue surged by over 110%, reaching approximately 280 billion in 2024. In contrast, Bio-Techne's revenue grew by around 224%, peaking at nearly 1.16 billion in the same year.

This analysis highlights the resilience and strategic prowess of Dr. Reddy's, which maintained a steady upward trend despite market fluctuations. Meanwhile, Bio-Techne's impressive growth, albeit on a smaller scale, underscores its potential in the biotech sector. As we look to the future, these companies' trajectories offer valuable insights into the dynamics of global healthcare markets.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025